glp-1 advertising crackdown news Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | & Announcements Glucagon-like peptide-1 - Wikipedia

Developmental origins of metabolic disease: life course and intergenerational perspectives

The peptide has also demonstrated interactions with the dopaminergic and serotonergic systems, with studies showing that BPC-157 can modulate the effects of dopamine-related agents in animal models and counteract some behavioural and neurochemical consequences of both dopamine agonists and antagonists (Sikiric et al., 2010)

2 weeks ago Not a stimulant, which is exactly what I wanted

Given its role in skin elasticity and wrinkle reduction, it makes sense that if you somehow can increase it, its going to make a difference to how we look, Vasenina says

It causes a shift from eumelanin generation to pheomelanin in the skin